New hope for stubborn diabetes: third pill in the works
NCT ID NCT07379333
Summary
This study is testing a new drug called HM11260C for adults with type 2 diabetes whose blood sugar is still too high despite taking two common medications (metformin and dapagliflozin). About 118 participants will be randomly assigned to receive either the new drug or a placebo (dummy pill) for 36 weeks to see if it safely improves long-term blood sugar control. The main goal is to see how much it lowers a key blood sugar marker (HbA1c) compared to the start of the study.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Catholic University of Korea Bucheon St. Mary's Hospital
Gyeonggi-do, South Korea
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.